Vivid Seats (SEATW) Financials

$0.31 +0.07 (+26.26%)

As of 05/21/2025 01:55 PM Eastern

Annual Income Statements for Vivid Seats

This table shows Vivid Seats' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	13	69	71
Consolidated Net Income / (Loss)	14	113	71
Net Income / (Loss) Continuing Operations	14	113	71
Total Pre-Tax Income	23	71	69
Total Operating Income	42	81	78
Total Gross Profit	574	531	460
Total Revenue	776	713	600
Operating Revenue	776	713	600
Total Cost of Revenue	202	182	141
Operating Cost of Revenue	202	182	141
Total Operating Expenses	532	449	382
Selling, General & Admin Expense	202	159	128
Marketing Expense	285	274	248
Depreciation Expense	44	17	7.73
Other Operating Expenses / (Income)	0.00	-1.00	-2.07
Total Other Income / (Expense), net	-20	-10	-8.92
Interest Expense	23	14	17
Other Income / (Expense), net	3.67	3.11	8.23
Income Tax Expense	8.42	-42	-1.59
Net Income / (Loss) Attributable to Noncontrolling Interest	9.43	75	29
Basic Earnings per Share	$0.07	$0.80	$0.36
Weighted Average Basic Shares Outstanding	132.33M	92.68M	80.26M
Diluted Earnings per Share	$0.06	$0.26	$0.36
Weighted Average Diluted Shares Outstanding	209.14M	198.88M	198.74M
Weighted Average Basic & Diluted Shares Outstanding	208.92M	210.18M	195.38M

This table shows Vivid Seats' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	3.12	5.30	-1.06	6.08	20	6.68	31	12	59	7.66
Consolidated Net Income / (Loss)	-8.76	11	-0.44	13	52	18	14	30	25	19
Net Income / (Loss) Continuing Operations	-4.42	9.20	-1.22	11	29	16	38	30	33	19
Total Pre-Tax Income	-3.13	13	-0.64	13	7.93	19	14	31	32	19
Total Operating Income	2.90	11	7.88	21	10	20	18	34	25	22
Total Gross Profit	147	136	150	141	147	138	123	123	225	119
Total Revenue	200	187	198	191	198	188	165	161	296	157
Operating Revenue	200	187	198	191	198	188	165	161	-	157
Total Cost of Revenue	52	51	49	50	51	50	43	38	70	38
Operating Cost of Revenue	52	51	49	50	51	50	43	38	-	38
Total Operating Expenses	144	125	142	121	137	118	105	90	185	98
Selling, General & Admin Expense	52	46	61	42	51	37	38	32	61	30
Marketing Expense	79	68	70	68	77	77	65	55	-	66
Depreciation Expense	13	11	11	10	8.58	3.30	2.70	2.60	2.46	2.16
Total Other Income / (Expense), net	-6.04	2.72	-8.53	-7.66	-2.17	-1.51	-3.77	-2.95	-8.27	-2.84
Interest Expense	6.47	6.30	5.32	5.08	4.91	2.54	2.77	3.28	7.60	2.90
Other Income / (Expense), net	0.43	9.02	-3.20	-2.58	2.74	1.04	-1.00	0.33	-	0.07
Income Tax Expense	1.28	4.29	0.58	2.27	-21	2.60	-24	0.29	-1.71	0.12
Net Income / (Loss) Attributable to Noncontrolling Interest	0.53	5.30	-1.06	4.67	19	6.68	31	18	3.17	11
Basic Earnings per Share	($0.01)	$0.04	($0.01)	$0.05	$0.21	$0.07	$0.36	$0.16	$0.13	$0.09
Weighted Average Basic Shares Outstanding	132.33M	131.52M	131.80M	134.07M	92.68M	96.41M	85.27M	77.41M	80.26M	82.00M
Diluted Earnings per Share	($0.01)	$0.04	($0.01)	$0.04	($0.16)	$0.07	$0.20	$0.15	$0.13	$0.09
Weighted Average Diluted Shares Outstanding	209.14M	131.95M	208.03M	210.91M	198.88M	96.86M	196.38M	195.82M	198.74M	82.02M
Weighted Average Basic & Diluted Shares Outstanding	208.92M	207.75M	208.08M	207.65M	210.18M	196.41M	196.18M	195.88M	195.38M	199.50M

This table details how cash moves in and out of Vivid Seats' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	112	-120	-238
Net Cash From Operating Activities	54	147	14
Net Cash From Continuing Operating Activities	54	147	13
Net Income / (Loss) Continuing Operations	14	113	71
Consolidated Net Income / (Loss)	14	113	71
Depreciation Expense	44	17	7.73
Amortization Expense	0.99	0.92	1.05
Non-Cash Adjustments To Reconcile Net Income	52	25	18
Changes in Operating Assets and Liabilities, net	-58	-9.10	-85
Net Cash From Investing Activities	-27	-226	-15
Net Cash From Continuing Investing Activities	-27	-226	-15
Purchase of Property, Plant & Equipment	-4.23	-0.90	-3.56
Acquisitions	-0.35	-207	-0.01
Other Investing Activities, net	-22	-18	-12
Net Cash From Financing Activities	86	-43	-236
Net Cash From Continuing Financing Activities	86	-43	-236
Repayment of Debt	-2.97	-0.28	-4.86
Repurchase of Common Equity	-23	-20	-32
Payment of Dividends	-10	-14	-5.25
Issuance of Debt	0.00	0.00	275
Other Financing Activities, net	122	-8.76	-469
Effect of Exchange Rate Changes	-1.05	1.90	0.00
Cash Interest Paid	19	19	15
Cash Income Taxes Paid	5.47	4.02	0.00

This table details how cash moves in and out of Vivid Seats' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	32	-32	81	31	-114	-61	2.88	52	-22	-14
Net Cash From Operating Activities	48	-19	-14	39	33	32	18	65	13	-0.02
Net Cash From Continuing Operating Activities	43	-18	-13	41	56	28	-1.18	65	11	0.00
Net Income / (Loss) Continuing Operations	-8.76	11	-0.44	13	51	18	14	30	25	19
Consolidated Net Income / (Loss)	-8.76	11	-0.44	13	51	18	14	30	25	19
Depreciation Expense	13	11	11	10	8.58	-2.00	8.01	2.60	2.46	2.16
Amortization Expense	0.27	0.27	0.22	0.24	0.24	0.24	0.23	0.23	0.23	0.24
Non-Cash Adjustments To Reconcile Net Income	18	2.08	21	11	4.66	31	-16	5.36	4.35	5.49
Changes in Operating Assets and Liabilities, net	21	-41	-44	6.26	-9.06	-20	-7.10	27	-21	-27
Net Cash From Investing Activities	-8.90	-7.29	-5.26	-5.29	-155	-65	-2.98	-2.61	-3.53	-4.96
Net Cash From Continuing Investing Activities	-8.90	-7.29	-5.26	-5.29	-155	-70	2.00	-2.61	-3.53	-4.96
Purchase of Property, Plant & Equipment	-3.46	-0.39	-0.29	-0.09	-0.11	-0.18	-0.39	-0.22	-0.83	-1.34
Acquisitions	-0.35	-	-	-	-151	-	-	-	-	-
Other Investing Activities, net	-5.10	-6.90	-4.98	-5.20	-3.57	-	-	-2.39	-2.70	-3.62
Net Cash From Financing Activities	-1.80	-6.84	99	-4.61	-17	-4.19	-12	-11	-32	-8.66
Net Cash From Continuing Financing Activities	-1.80	-6.84	99	-4.61	-17	-18	1.81	-11	-32	-8.66
Repurchase of Common Equity	0.02	-2.93	-17	-3.11	-12	-	-	-7.61	-29	-3.05
Payment of Dividends	-0.76	-2.84	-	-	-3.29	-	-	-	1.05	-5.61
Issuance of Debt	-126	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	124	-1.07	-0.10	-1.23	-0.69	-6.69	1.81	-3.19	-3.17	-
Cash Interest Paid	2.77	0.62	10	6.07	6.08	5.99	5.32	1.94	4.91	3.60
Cash Income Taxes Paid	0.33	1.86	2.66	0.62	3.62	-	0.40	0.00	-	-

This table presents Vivid Seats' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,636	1,550	1,151
Total Current Assets	345	246	332
Cash & Equivalents	243	125	252
Restricted Cash	1.17	6.95	0.75
Accounts Receivable	48	58	37
Inventories, net	20	21	13
Prepaid Expenses	33	34	30
Plant, Property, & Equipment, net	13	10	10
Total Noncurrent Assets	1,278	1,294	809
Goodwill	943	947	715
Intangible Assets	233	241	82
Noncurrent Deferred & Refundable Income Taxes	78	86	0.00
Other Noncurrent Operating Assets	24	20	12
Total Liabilities & Shareholders' Equity	1,636	1,550	1,151
Total Liabilities	1,022	963	671
Total Current Liabilities	426	488	378
Short-Term Debt	3.95	3.93	2.75
Accounts Payable	233	258	161
Accrued Expenses	165	192	182
Current Deferred Revenue	24	35	32
Total Noncurrent Liabilities	596	476	293
Long-Term Debt	404	281	280
Noncurrent Deferred & Payable Income Tax Liabilities	156	166	0.00
Other Noncurrent Operating Liabilities	37	29	13
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	353	482	863
Total Equity & Noncontrolling Interests	261	105	-383
Total Preferred & Common Equity	261	105	-383
Total Common Equity	261	105	-383
Common Stock	1,268	1,096	664
Retained Earnings	-930	-940	-1,014
Treasury Stock	-76	-53	-32
Accumulated Other Comprehensive Income / (Loss)	-0.88	0.75	0.00

This table presents Vivid Seats' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,611	1,655	1,589	1,385	1,325	1,228	1,181
Total Current Assets	326	371	297	406	428	408	364
Cash & Equivalents	202	234	154	269	306	303	274
Restricted Cash	6.19	6.14	6.85	1.06	0.67	0.68	0.51
Accounts Receivable	65	69	70	65	46	47	40
Inventories, net	22	30	30	22	28	24	14
Prepaid Expenses	30	32	37	49	47	33	35
Plant, Property, & Equipment, net	9.59	9.66	9.83	10	10	10	8.84
Total Noncurrent Assets	1,275	1,274	1,283	969	887	809	808
Goodwill	947	942	944	760	715	715	715
Intangible Assets	225	227	234	114	82	82	82
Noncurrent Deferred & Refundable Income Taxes	81	85	85	77	79	-	-
Other Noncurrent Operating Assets	22	21	20	18	9.97	12	11
Total Liabilities & Shareholders' Equity	1,611	1,655	1,589	1,385	1,325	1,228	1,181
Total Liabilities	999	1,061	993	865	828	723	701
Total Current Liabilities	413	470	525	454	429	431	405
Short-Term Debt	3.95	3.95	3.58	3.31	2.75	2.75	2.75
Accounts Payable	224	267	307	219	204	218	165
Accrued Expenses	160	169	181	197	192	184	204
Current Deferred Revenue	25	30	33	34	30	26	34
Total Noncurrent Liabilities	586	591	468	411	399	292	295
Long-Term Debt	402	403	280	282	279	279	279
Noncurrent Deferred & Payable Income Tax Liabilities	162	162	160	99	99	-	-
Other Noncurrent Operating Liabilities	23	26	28	30	21	13	16
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	282	438	457	641	790	902	905
Total Equity & Noncontrolling Interests	329	156	140	-120	-293	-397	-425
Total Preferred & Common Equity	329	156	140	-120	-293	-397	-425
Total Common Equity	329	156	140	-120	-293	-397	-425
Common Stock	1,334	1,164	1,130	885	718	645	602
Retained Earnings	-929	-935	-934	-965	-971	-1,002	-1,024
Treasury Stock	-76	-73	-57	-40	-40	-40	-3.05
Accumulated Other Comprehensive Income / (Loss)	0.77	-1.22	-0.38	-0.17	-	-	-

This table displays calculated financial ratios and metrics derived from Vivid Seats' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	8.80%	18.76%	35.49%
EBITDA Growth	-11.15%	7.81%	16.03%
EBIT Growth	-45.66%	-2.18%	14.83%
NOPAT Growth	-79.51%	62.35%	49.07%
Net Income Growth	-87.36%	59.85%	470.01%
EPS Growth	-76.92%	-27.78%	1,000.00%
Operating Cash Flow Growth	-63.40%	924.83%	-91.82%
Free Cash Flow Firm Growth	88.54%	-183.73%	-116.90%
Invested Capital Growth	5.13%	44.80%	29.01%
Revenue Q/Q Growth	0.20%	-12.03%	21.88%
EBITDA Q/Q Growth	-5.66%	-5.03%	-10.40%
EBIT Q/Q Growth	-17.16%	-12.03%	-12.70%
NOPAT Q/Q Growth	-61.54%	8.41%	-18.31%
Net Income Q/Q Growth	-80.83%	30.94%	52.93%
EPS Q/Q Growth	166.67%	-52.73%	89.47%
Operating Cash Flow Q/Q Growth	38.02%	15.66%	137.75%
Free Cash Flow Firm Q/Q Growth	94.43%	-238.80%	0.00%
Invested Capital Q/Q Growth	-3.89%	37.94%	4.72%
Profitability Metrics	-	-	-
Gross Margin	73.97%	74.44%	76.59%
EBITDA Margin	11.75%	14.39%	15.85%
Operating Margin	5.44%	11.41%	13.01%
EBIT Margin	5.92%	11.85%	14.38%
Profit (Net Income) Margin	1.84%	15.87%	11.79%
Tax Burden Percent	62.95%	159.48%	102.30%
Interest Burden Percent	49.51%	84.01%	80.14%
Effective Tax Rate	37.05%	-59.48%	-2.30%
Return on Invested Capital (ROIC)	3.51%	20.76%	17.64%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.28%	2.60%	-3,068.96%
Return on Net Nonoperating Assets (RNNOA)	-1.12%	0.45%	-2.00%
Return on Equity (ROE)	2.38%	21.21%	15.63%
Cash Return on Invested Capital (CROIC)	-1.50%	-15.84%	-7.70%
Operating Return on Assets (OROA)	2.88%	6.25%	6.74%
Return on Assets (ROA)	0.90%	8.38%	5.53%
Return on Common Equity (ROCE)	0.73%	-5.52%	-21.47%
Return on Equity Simple (ROE_SIMPLE)	5.48%	107.74%	-18.49%
Net Operating Profit after Tax (NOPAT)	27	130	80
NOPAT Margin	3.43%	18.20%	13.31%
Net Nonoperating Expense Percent (NNEP)	7.79%	18.16%	3,086.60%
Return On Investment Capital (ROIC_SIMPLE)	3.97%	33.28%	-79.79%
Cost of Revenue to Revenue	26.03%	25.56%	23.41%
SG&A Expenses to Revenue	26.06%	22.32%	21.26%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	68.53%	63.03%	63.58%
Earnings before Interest and Taxes (EBIT)	46	84	86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	91	103	95
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	3.68	11.82	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.24	1.74	2.43
Price to Earnings (P/E)	71.64	17.88	20.57
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	1.40%	5.59%	4.86%
Enterprise Value to Invested Capital (EV/IC)	1.90	2.54	4.60
Enterprise Value to Revenue (EV/Rev)	1.91	2.63	3.91
Enterprise Value to EBITDA (EV/EBITDA)	16.22	18.29	24.70
Enterprise Value to EBIT (EV/EBIT)	32.20	22.21	27.21
Enterprise Value to NOPAT (EV/NOPAT)	55.59	14.46	29.41
Enterprise Value to Operating Cash Flow (EV/OCF)	27.41	12.73	163.44
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.66	0.49	0.59
Long-Term Debt to Equity	0.66	0.48	0.58
Financial Leverage	0.26	0.17	0.00
Leverage Ratio	2.65	2.53	2.83
Compound Leverage Factor	1.31	2.13	2.27
Debt to Total Capital	39.90%	32.68%	37.05%
Short-Term Debt to Total Capital	0.39%	0.45%	0.36%
Long-Term Debt to Total Capital	39.51%	32.22%	36.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	34.54%	55.27%	113.13%
Common Equity to Total Capital	25.56%	12.05%	-50.18%
Debt to EBITDA	4.47	2.78	2.97
Net Debt to EBITDA	1.79	1.49	0.32
Long-Term Debt to EBITDA	4.43	2.74	2.94
Debt to NOPAT	15.34	2.20	3.54
Net Debt to NOPAT	6.13	1.17	0.38
Long-Term Debt to NOPAT	15.19	2.17	3.50
Altman Z-Score	0.28	0.38	0.79
Noncontrolling Interest Sharing Ratio	69.51%	126.03%	237.32%
Liquidity Ratios	-	-	-
Current Ratio	0.81	0.50	0.88
Quick Ratio	0.69	0.38	0.76
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-11	-99	-35
Operating Cash Flow to CapEx	1,275.66%	16,460.34%	404.02%
Free Cash Flow to Firm to Interest Expense	-0.49	-7.33	-2.03
Operating Cash Flow to Interest Expense	2.33	10.91	0.84
Operating Cash Flow Less CapEx to Interest Expense	2.14	10.84	0.63
Efficiency Ratios	-	-	-
Asset Turnover	0.49	0.53	0.47
Accounts Receivable Turnover	14.52	15.01	16.52
Inventory Turnover	9.94	10.78	11.44
Fixed Asset Turnover	68.26	69.26	104.28
Accounts Payable Turnover	0.82	0.87	0.80
Days Sales Outstanding (DSO)	25.13	24.32	22.09
Days Inventory Outstanding (DIO)	36.72	33.86	31.89
Days Payable Outstanding (DPO)	443.47	419.55	457.86
Cash Conversion Cycle (CCC)	-381.61	-361.37	-403.88
Capital & Investment Metrics	-	-	-
Invested Capital	777	739	510
Invested Capital Turnover	1.02	1.14	1.33
Increase / (Decrease) in Invested Capital	38	229	115
Enterprise Value (EV)	1,478	1,875	2,349
Market Capitalization	962	1,241	1,456
Book Value per Share	$1.26	$0.53	($1.92)
Tangible Book Value per Share	($4.41)	($5.52)	($5.91)
Total Capital	1,022	872	763
Total Debt	408	285	283
Total Long-Term Debt	404	281	280
Net Debt	163	152	30
Capital Expenditures (CapEx)	4.23	0.90	3.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-321	-370	-296
Debt-free Net Working Capital (DFNWC)	-77	-238	-44
Net Working Capital (NWC)	-81	-242	-46
Net Nonoperating Expense (NNE)	12	17	9.12
Net Nonoperating Obligations (NNO)	163	152	30
Total Depreciation and Amortization (D&A)	45	18	8.78
Debt-free, Cash-free Net Working Capital to Revenue	-41.43%	-51.94%	-49.32%
Debt-free Net Working Capital to Revenue	-9.88%	-33.36%	-7.29%
Net Working Capital to Revenue	-10.39%	-33.91%	-7.75%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.07	$0.80	$0.36
Adjusted Weighted Average Basic Shares Outstanding	132.33M	92.68M	80.26M
Adjusted Diluted Earnings per Share	$0.06	$0.26	$0.36
Adjusted Weighted Average Diluted Shares Outstanding	209.14M	198.88M	198.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	208.92M	210.18M	195.38M
Normalized Net Operating Profit after Tax (NOPAT)	27	57	55
Normalized NOPAT Margin	3.43%	7.99%	9.11%
Pre Tax Income Margin	2.93%	9.95%	11.53%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	1.98	6.25	5.04
NOPAT to Interest Expense	1.15	9.61	4.66
EBIT Less CapEx to Interest Expense	1.80	6.19	4.83
NOPAT Less CapEx to Interest Expense	0.96	9.54	4.45
Payout Ratios	-	-	-
Dividend Payout Ratio	70.02%	12.64%	7.41%
Augmented Payout Ratio	230.71%	30.40%	53.32%

This table displays calculated financial ratios and metrics derived from Vivid Seats' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.76%	-0.81%	19.92%	18.50%	-32.95%	19.97%	11.97%	0.00%	57.32%	12.38%
EBITDA Growth	-25.24%	58.42%	-38.02%	-21.41%	-21.13%	-19.77%	-13.52%	137.53%	-41.23%	37.14%
EBIT Growth	-74.05%	-6.48%	-71.83%	-46.53%	-48.14%	-2.80%	-37.92%	146.63%	-45.65%	40.68%
NOPAT Growth	-94.41%	-57.60%	-88.69%	-48.58%	39.15%	-19.71%	172.05%	245.66%	11.05%	99.12%
Net Income Growth	-116.99%	-39.85%	-103.20%	-57.49%	107.70%	-5.80%	-43.28%	864.69%	7,560.49%	1,115.76%
EPS Growth	93.75%	-42.86%	-105.00%	-73.33%	-223.08%	-22.22%	66.67%	650.00%	425.00%	0.00%
Operating Cash Flow Growth	45.10%	-160.61%	-178.63%	-39.85%	153.61%	186,664.71%	179.35%	176.67%	132.90%	-100.05%
Free Cash Flow Firm Growth	81.34%	-754.61%	-1,256.82%	-304.40%	-116.92%	-158.02%	105.70%	85.97%	0.00%	97.28%
Invested Capital Growth	5.13%	50.89%	61.19%	48.89%	44.80%	9.92%	5.43%	22.09%	29.01%	7.40%
Revenue Q/Q Growth	7.08%	-5.91%	3.91%	-3.76%	5.41%	13.76%	2.68%	-45.54%	88.60%	6.18%
EBITDA Q/Q Growth	-47.31%	99.49%	-46.55%	33.07%	11.65%	-21.96%	-32.23%	33.54%	13.59%	-15.88%
EBIT Q/Q Growth	-83.16%	322.78%	-74.13%	40.91%	-39.31%	27.35%	-50.90%	36.68%	13.74%	-18.66%
NOPAT Q/Q Growth	-72.33%	33.06%	-67.68%	-52.99%	109.72%	-64.50%	46.91%	27.22%	21.01%	20.29%
Net Income Q/Q Growth	-182.42%	2,532.49%	-103.40%	-75.03%	191.71%	29.50%	-54.92%	21.97%	32.30%	-22.02%
EPS Q/Q Growth	-125.00%	500.00%	-125.00%	144.44%	-328.57%	-65.00%	33.33%	15.38%	44.44%	-25.00%
Operating Cash Flow Q/Q Growth	348.58%	-39.24%	-135.25%	18.92%	3.84%	80.63%	-73.03%	401.39%	76,488.24%	99.92%
Free Cash Flow Firm Q/Q Growth	86.47%	6.26%	-29.35%	-13.77%	-519.54%	-226.88%	145.22%	38.98%	-636.93%	97.20%
Invested Capital Q/Q Growth	-3.89%	6.35%	5.81%	-2.79%	37.94%	13.61%	-2.27%	-5.46%	4.72%	8.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	73.74%	72.65%	75.41%	74.02%	74.11%	73.18%	74.23%	76.56%	76.17%	76.01%
EBITDA Margin	8.10%	16.46%	7.76%	15.10%	10.92%	10.31%	15.02%	22.76%	9.28%	15.41%
Operating Margin	1.45%	5.77%	3.97%	10.83%	5.09%	10.69%	10.65%	20.81%	8.37%	13.84%
EBIT Margin	1.67%	10.60%	2.36%	9.48%	6.47%	11.25%	10.05%	21.01%	8.37%	13.88%
Profit (Net Income) Margin	-4.38%	5.70%	-0.22%	6.74%	26.00%	9.39%	8.25%	18.80%	8.39%	11.96%
Tax Burden Percent	279.55%	78.82%	67.86%	98.92%	649.99%	94.94%	98.59%	99.07%	78.57%	99.45%
Interest Burden Percent	-94.06%	68.16%	-13.76%	71.91%	61.77%	87.98%	83.31%	90.31%	127.60%	86.67%
Effective Tax Rate	0.00%	31.81%	0.00%	17.44%	-259.66%	13.94%	-176.90%	0.93%	-5.41%	0.63%
Return on Invested Capital (ROIC)	1.04%	4.53%	3.50%	11.06%	20.89%	14.58%	50.00%	35.75%	11.69%	14.39%
ROIC Less NNEP Spread (ROIC-NNEP)	-5.80%	7.63%	-4.96%	2.69%	37.58%	17.71%	248.25%	45.70%	-419.96%	13.31%
Return on Net Nonoperating Assets (RNNOA)	-1.52%	1.43%	-0.64%	0.25%	6.43%	0.40%	-9.22%	-2.87%	-0.27%	16.44%
Return on Equity (ROE)	-0.48%	5.96%	2.86%	11.31%	27.33%	14.98%	40.78%	32.88%	11.42%	30.83%
Cash Return on Invested Capital (CROIC)	-1.50%	-30.29%	-33.60%	-19.29%	-15.84%	13.93%	21.72%	2.69%	-7.70%	0.00%
Operating Return on Assets (OROA)	0.81%	5.48%	1.23%	5.00%	3.42%	7.10%	6.14%	12.79%	3.93%	5.27%
Return on Assets (ROA)	-2.13%	2.94%	-0.11%	3.56%	13.72%	5.93%	5.05%	11.44%	3.94%	4.54%
Return on Common Equity (ROCE)	-0.15%	1.10%	-0.36%	-2.65%	-7.11%	-8.17%	-30.72%	-44.67%	-15.68%	-53.32%
Return on Equity Simple (ROE_SIMPLE)	0.00%	22.65%	52.41%	68.61%	0.00%	-71.84%	-29.83%	-24.65%	0.00%	-10.88%
Net Operating Profit after Tax (NOPAT)	2.03	7.34	5.52	17	36	17	49	33	26	22
NOPAT Margin	1.02%	3.93%	2.78%	8.94%	18.31%	9.20%	29.49%	20.61%	8.82%	13.75%
Net Nonoperating Expense Percent (NNEP)	6.85%	-3.10%	8.46%	8.37%	-16.69%	-3.13%	-198.25%	-9.95%	431.65%	1.08%
Return On Investment Capital (ROIC_SIMPLE)	0.30%	-	-	-	9.32%	-	-	-	-26.06%	-
Cost of Revenue to Revenue	26.26%	27.35%	24.59%	25.98%	25.89%	26.82%	25.77%	23.44%	23.83%	23.99%
SG&A Expenses to Revenue	26.22%	24.82%	30.79%	22.20%	25.80%	19.79%	23.16%	20.11%	20.68%	19.28%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	72.28%	66.88%	71.44%	63.19%	69.02%	62.48%	63.58%	55.75%	62.70%	62.17%
Earnings before Interest and Taxes (EBIT)	3.33	20	4.68	18	13	21	17	34	25	22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16	31	15	29	22	19	25	37	27	24
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.68	2.34	7.66	9.02	11.82	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.24	0.99	1.54	1.70	1.74	1.55	1.99	1.96	2.43	3.11
Price to Earnings (P/E)	71.64	25.53	37.85	19.88	17.88	11.62	14.19	16.88	20.57	34.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.00%
Earnings Yield	1.40%	3.92%	2.64%	5.03%	5.59%	8.60%	7.05%	5.92%	4.86%	2.94%
Enterprise Value to Invested Capital (EV/IC)	1.90	1.54	2.37	2.56	2.54	3.58	4.91	4.91	4.60	5.02
Enterprise Value to Revenue (EV/Rev)	1.91	1.61	2.32	2.47	2.63	2.36	2.97	3.11	3.91	4.97
Enterprise Value to EBITDA (EV/EBITDA)	16.22	12.93	21.10	19.41	18.29	17.74	20.37	21.99	24.70	23.05
Enterprise Value to EBIT (EV/EBIT)	32.20	22.54	31.68	26.75	22.21	19.95	23.74	24.22	27.21	24.74
Enterprise Value to NOPAT (EV/NOPAT)	55.59	18.07	22.02	15.30	14.46	16.01	18.66	23.92	29.41	25.02
Enterprise Value to Operating Cash Flow (EV/OCF)	27.41	31.97	19.98	15.14	12.73	15.04	24.22	42.37	163.44	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	26.87	23.21	200.96	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.66	0.66	0.68	0.48	0.49	0.55	0.57	0.56	0.59	0.59
Long-Term Debt to Equity	0.66	0.66	0.68	0.47	0.48	0.54	0.56	0.55	0.58	0.58
Financial Leverage	0.26	0.19	0.13	0.09	0.17	0.02	-0.04	-0.06	0.00	1.23
Leverage Ratio	2.65	2.65	2.73	2.56	2.53	2.56	2.67	2.67	2.83	6.16
Compound Leverage Factor	-2.50	1.80	-0.38	1.84	1.56	2.26	2.22	2.41	3.61	5.34
Debt to Total Capital	39.90%	39.87%	40.63%	32.21%	32.68%	35.39%	36.15%	35.85%	37.05%	37.00%
Short-Term Debt to Total Capital	0.39%	0.39%	0.39%	0.41%	0.45%	0.41%	0.35%	0.35%	0.36%	0.36%
Long-Term Debt to Total Capital	39.51%	39.48%	40.23%	31.80%	32.22%	34.98%	35.80%	35.50%	36.69%	36.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	34.54%	27.73%	43.80%	51.92%	55.27%	79.54%	101.53%	114.66%	113.13%	118.84%
Common Equity to Total Capital	25.56%	32.39%	15.57%	15.87%	12.05%	-14.93%	-37.68%	-50.51%	-50.18%	-55.85%
Debt to EBITDA	4.47	4.20	4.77	2.99	2.78	2.64	2.47	2.62	2.97	2.66
Net Debt to EBITDA	1.79	2.04	1.95	1.29	1.49	0.14	-0.22	-0.20	0.32	0.07
Long-Term Debt to EBITDA	4.43	4.16	4.72	2.95	2.74	2.61	2.45	2.59	2.94	2.63
Debt to NOPAT	15.34	5.87	4.98	2.36	2.20	2.38	2.27	2.85	3.54	2.88
Net Debt to NOPAT	6.13	2.85	2.03	1.02	1.17	0.13	-0.21	-0.22	0.38	0.08
Long-Term Debt to NOPAT	15.19	5.81	4.93	2.33	2.17	2.36	2.25	2.82	3.50	2.85
Altman Z-Score	0.19	0.11	0.29	0.27	0.22	0.49	0.73	0.78	0.61	0.54
Noncontrolling Interest Sharing Ratio	69.51%	81.52%	112.60%	123.41%	126.03%	154.55%	175.33%	235.86%	237.32%	272.97%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.81	0.79	0.79	0.57	0.50	0.89	1.00	0.95	0.88	0.90
Quick Ratio	0.69	0.65	0.65	0.43	0.38	0.73	0.82	0.81	0.76	0.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-36	-265	-283	-219	-192	-31	24	-54	-89	-12
Operating Cash Flow to CapEx	1,381.13%	-4,941.90%	-4,827.27%	42,570.65%	29,940.00%	17,718.44%	4,490.79%	30,284.19%	1,562.70%	-1.27%
Free Cash Flow to Firm to Interest Expense	-5.55	-42.12	-53.17	-43.06	-39.19	-12.20	8.83	-16.50	-11.67	-4.15
Operating Cash Flow to Interest Expense	7.39	-3.05	-2.59	7.71	6.71	12.47	6.33	19.85	1.71	-0.01
Operating Cash Flow Less CapEx to Interest Expense	6.86	-3.11	-2.65	7.69	6.69	12.40	6.19	19.79	1.60	-0.47
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.49	0.52	0.52	0.53	0.53	0.63	0.61	0.61	0.47	0.38
Accounts Receivable Turnover	14.52	11.90	13.50	12.78	15.01	15.39	17.18	15.15	16.52	10.42
Inventory Turnover	9.94	9.17	6.87	7.23	10.78	11.29	7.66	8.48	11.44	6.80
Fixed Asset Turnover	68.26	78.08	77.49	73.75	69.26	84.93	114.15	126.75	104.28	103.61
Accounts Payable Turnover	0.82	0.91	0.85	0.74	0.87	1.05	0.95	0.78	0.80	0.57
Days Sales Outstanding (DSO)	25.13	30.68	27.04	28.55	24.32	23.72	21.24	24.09	22.09	35.03
Days Inventory Outstanding (DIO)	36.72	39.81	53.12	50.48	33.86	32.32	47.66	43.05	31.89	53.66
Days Payable Outstanding (DPO)	443.47	403.19	429.20	494.37	419.55	348.55	383.15	465.22	457.86	638.17
Cash Conversion Cycle (CCC)	-381.61	-332.69	-349.03	-415.34	-361.37	-292.51	-314.26	-398.08	-403.88	-549.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	777	808	760	718	739	536	472	483	510	487
Invested Capital Turnover	1.02	1.15	1.26	1.24	1.14	1.58	1.70	1.73	1.33	1.05
Increase / (Decrease) in Invested Capital	38	273	289	236	229	48	24	87	115	34
Enterprise Value (EV)	1,478	1,249	1,798	1,838	1,875	1,916	2,316	2,371	2,349	2,447
Market Capitalization	962	770	1,194	1,259	1,241	1,260	1,551	1,491	1,456	1,534
Book Value per Share	$1.26	$1.58	$0.75	$0.66	$0.53	($0.61)	($1.50)	($2.03)	($1.92)	($2.12)
Tangible Book Value per Share	($4.41)	($4.05)	($4.88)	($4.94)	($5.52)	($5.07)	($5.57)	($6.11)	($5.91)	($6.10)
Total Capital	1,022	1,017	1,001	879	872	806	779	787	763	762
Total Debt	408	405	407	283	285	285	281	282	283	282
Total Long-Term Debt	404	402	403	280	281	282	279	279	280	279
Net Debt	163	197	166	122	152	15	-25	-22	30	7.50
Capital Expenditures (CapEx)	3.46	0.39	0.29	0.09	0.11	0.18	0.39	0.22	0.83	1.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-321	-291	-335	-386	-370	-315	-305	-324	-296	-313
Debt-free Net Working Capital (DFNWC)	-77	-83	-95	-225	-238	-45	1.47	-20	-44	-38
Net Working Capital (NWC)	-81	-87	-99	-228	-242	-49	-1.28	-23	-46	-41
Net Nonoperating Expense (NNE)	11	-3.29	5.95	4.20	-15	-0.36	35	2.93	1.28	2.80
Net Nonoperating Obligations (NNO)	163	197	166	122	152	15	-25	-22	30	7.50
Total Depreciation and Amortization (D&A)	13	11	11	11	8.81	-1.77	8.23	2.82	2.70	2.40
Debt-free, Cash-free Net Working Capital to Revenue	-41.43%	-37.63%	-43.23%	-51.92%	-51.94%	-38.88%	-39.20%	-42.53%	-49.32%	-63.53%
Debt-free Net Working Capital to Revenue	-9.88%	-10.70%	-12.23%	-30.26%	-33.36%	-5.59%	0.19%	-2.60%	-7.29%	-7.82%
Net Working Capital to Revenue	-10.39%	-11.21%	-12.74%	-30.74%	-33.91%	-6.00%	-0.16%	-2.96%	-7.75%	-8.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.01)	$0.04	($0.01)	$0.05	$0.21	$0.00	$0.36	$0.16	$0.13	$0.09
Adjusted Weighted Average Basic Shares Outstanding	132.33M	131.52M	131.80M	134.07M	92.68M	96.41M	85.27M	77.41M	80.26M	82.00M
Adjusted Diluted Earnings per Share	($0.01)	$0.04	($0.01)	$0.04	($0.16)	$0.00	$0.20	$0.15	$0.13	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	209.14M	131.95M	208.03M	210.91M	198.88M	0.00	196.38M	195.82M	198.74M	82.02M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	208.92M	207.75M	208.08M	207.65M	210.18M	196.41M	196.18M	195.88M	195.38M	199.50M
Normalized Net Operating Profit after Tax (NOPAT)	2.03	7.34	5.52	17	7.07	17	12	33	17	22
Normalized NOPAT Margin	1.02%	3.93%	2.78%	8.94%	3.56%	9.20%	7.46%	20.61%	5.86%	13.75%
Pre Tax Income Margin	-1.57%	7.23%	-0.32%	6.82%	4.00%	9.89%	8.37%	18.97%	10.68%	12.03%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.52	3.14	0.88	3.56	2.62	8.32	5.99	10.32	3.26	7.50
NOPAT to Interest Expense	0.31	1.17	1.04	3.36	7.40	6.81	17.59	10.12	3.43	7.43
EBIT Less CapEx to Interest Expense	-0.02	3.08	0.83	3.54	2.59	8.25	5.85	10.25	3.15	7.04
NOPAT Less CapEx to Interest Expense	-0.22	1.10	0.98	3.34	7.37	6.74	17.45	10.06	3.32	6.97
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	70.02%	16.81%	0.00%	0.00%	12.64%	11.54%	0.00%	0.00%	7.41%	613.60%
Augmented Payout Ratio	230.71%	64.36%	39.86%	16.28%	30.40%	54.42%	45.84%	40.96%	53.32%	613.60%

Frequently Asked Questions About Vivid Seats' Financials

When does Vivid Seats's fiscal year end?

According to the most recent income statement we have on file, Vivid Seats' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Vivid Seats' net income changed over the last 2 years?

Vivid Seats' net income appears to be on a downward trend, with a most recent value of $14.30 million in 2024, falling from $70.78 million in 2022. The previous period was $113.14 million in 2023.

What is Vivid Seats's operating income?

Vivid Seats's total operating income in 2024 was $42.23 million, based on the following breakdown:

Total Gross Profit: $573.73 million
Total Operating Expenses: $531.51 million

How has Vivid Seats revenue changed over the last 2 years?

Over the last 2 years, Vivid Seats' total revenue changed from $600.27 million in 2022 to $775.59 million in 2024, a change of 29.2%.

How much debt does Vivid Seats have?

Vivid Seats' total liabilities were at $1.02 billion at the end of 2024, a 6.1% increase from 2023, and a 52.3% increase since 2022.

How much cash does Vivid Seats have?

In the past 2 years, Vivid Seats' cash and equivalents has ranged from $125.48 million in 2023 to $251.54 million in 2022, and is currently $243.48 million as of their latest financial filing in 2024.

How has Vivid Seats' book value per share changed over the last 2 years?

Over the last 2 years, Vivid Seats' book value per share changed from -1.92 in 2022 to 1.26 in 2024, a change of -165.5%.

Related Companies

This page (NASDAQ:SEATW) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vivid Seats (SEATW) Financials

Frequently Asked Questions About Vivid Seats' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vivid Seats (SEATW) Financials

Annual Income Statements for Vivid Seats

Quarterly Income Statements for Vivid Seats

Annual Cash Flow Statements for Vivid Seats

Quarterly Cash Flow Statements for Vivid Seats

Annual Balance Sheets for Vivid Seats

Quarterly Balance Sheets for Vivid Seats

Annual Metrics And Ratios for Vivid Seats

Quarterly Metrics And Ratios for Vivid Seats

Frequently Asked Questions About Vivid Seats' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools